Weight gain during treatment course of allogenic hematopoietic stem cell transplantation in patients with hematological malignancies affects treatment outcome-Reference-Cited by-同舟云学术

Weight gain during treatment course of allogenic hematopoietic stem cell transplantation in patients with hematological malignancies affects treatment outcome

Published:2022-12 Issue:12 Volume:24 Page:1190-1194
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Johansen Silje,Blomberg Bjørn^ORCID,Vo Anh Khoi,Wendelbo Øystein,Reikvam Håkon^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference19 articles.

1. Allogeneic stem cell transplantation: A historical and scientific overview;Singh;Cancer Res,2016

2. The EBMT risk score;Gratwohl;Bone Marrow Transplant,2012

3. Impacts of pretransplant comorbidities on allogeneic hematopoietic cell transplantation (HCT) outcomes, biology of blood and marrow transplantation;Sorror;Biol Blood Marrow Transplant,2009

4. Weight loss and decrease of body mass index during allogeneic stem cell transplantation are common events with limited clinical impact;Rieger;PLoS One,2015

5. Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation;Urbain;Bone Marrow Transplant,2013

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease;Bone Marrow Transplantation;2023-09-08

2. Pretransplant systemic metabolic profiles in allogeneic hematopoietic stem cell transplant recipients - identification of patient subsets with increased transplant-related mortality;Transplantation and Cellular Therapy;2023-06